Reply to: "N-Terminal Pro-B-Type Natriuretic Peptide Levels in Parkinson's Disease"
Mov Disord
.
2020 Oct;35(10):1888.
doi: 10.1002/mds.28272.
Authors
Chi-Un Choe
1
,
Elina Petersen
2
,
Monika Pötter-Nerger
1
,
Carsten Buhmann
1
,
Stefan Blankenberg
3
4
,
Christian Gerloff
1
,
Edzard Schwedhelm
4
5
,
Tanja Zeller
3
4
Affiliations
1
Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
2
Epidemiological Study Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
3
Department of General and Interventional Cardiology, University Heart and Vascular Center, Hamburg, Germany.
4
German Center for Cardiovascular Research, German Center for Cardiovascular Research, Partner Site Hamburg/Lübeck/Kiel, Hamburg, Germany.
5
Institute of Clinical Pharmacology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
PMID:
33068470
DOI:
10.1002/mds.28272
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Cognition
Humans
Natriuretic Peptide, Brain*
Parkinson Disease*
Peptide Fragments
Substances
Peptide Fragments
Natriuretic Peptide, Brain